Global Chemicals Institute – Publications
Global Chemicals Institute – Publications
Welcome to the KPMG knowledge base of articles and publications that demonstrate our understanding of many of the complex business challenges and key issues faced by chemical companies around the world.
Deal Capsule – Transactions in Chemicals & Life Sciences January 2018
M&A activity stable in both sectors, despite a decline in deal value.
Digital transformation of the chemical industry
The chemical industry is subject to a different set of rules. The chemical industry must recognize that it too faces challenges with digitalization.
Deal Capsule - Transactions in Chemicals April 2017
Transactions in Chemicals focused on paints and coatings and plastics.
Deal Capsule – Transactions in Chemicals & Life Sciences January 2018
Life sciences M&A is driven by oncology and the shift towards precision medicine and digital health. In chemicals, consolidation in agrochemicals is ongoing and companies are keen to invest in technology start-ups as the potential of digitalization becomes increasingly apparent to the chemicals industry. In 2017, US and China were the most active countries in both sectors.
Deal Capsule – Transactions in Chemicals & Life Sciences October 2017
M&A activity remains solid in life sciences with a high number of announced deals, although deal values are not expected to hit the heady levels of 2014 and 2015. Oncology drives M&A in life sciences as key players seek to optimize their portfolios in anticipation of 10.9% CAGR growth to 2030. Chemical companies are increasingly focussing their M&A on application industries. Agrochemicals remains an M&A hotspot. The closing of the DowDuPont merger brought with it a spate of anti-trust divestments. US and China remain the most active countries in both sectors.
Deal Capsule - Transactions in Pharmaceuticals April 2017
Big pharma players continue to acquire biotechs, particularly in the oncology area. Venture Capital is also increasing investments in biotech assets.
Deal Capsule - Transactions in Chemicals April 2017
Transactions in Chemicals focused on paints and coatings and plastics.
Deal Capsule: Transactions in Chemicals - January 2017
In chemicals, several mega deals are close to completion. Activity was spread across the value chain with a focus on agrochemicals. PE activity was subdued due to high valuations.
Deal Capsule: Transactions in Pharmaceuticals - January 2017
Pharmaceutical M&A turned its focus on biotech targets to seize late-stage assets. Generics and animal health were further key areas of interest.
Global Rules of Competitiveness Embrace GCC Chemicals
Competitiveness in times of levelling differentiators.
Deal Capsule: Transactions in Chemicals - July 2016
Consolidation in agrochemicals continued, with Bayer proposing the $62 billion acquisition of Monsanto – the largest-ever all cash deal.
Deal Capsule: Transactions in Pharmaceuticals - July 2016
Pharmaceutical M&A was impacted by stock market volatility, while new US regulatory rules struck down the $160 billion Pfizer-Allergan merger.
Deal Capsule - Transactions in Chemicals April 2016
Downstream specialty chemicals was the leading focus area, notably in applications, resins and agrochemicals. KPMG’s Deal Thermometer indicates that the environment for M&A activity will remain moderately strong in chemicals.
Deal Capsule - Transactions in Pharmaceuticals April 2016
Specialization continues to be a driving force in Q1 2016, especially in sectors such as OTC, rare diseases and oncology. KPMG’s Deal Thermometer indicates that the environment for M&A activity will remain moderately strong in pharmaceuticals.
Deal Capsule - Transactions in Chemicals January 2016
Transactions in chemicals, on the other hand, are moving up the value chain as companies seek to strengthen their positions in the high - margin specialties segment. KPMG’s Deal Thermometer indicates that the environment for M&A activity will remain ‘Moderate’ in chemicals.
Deal Capsule - Transactions in Pharmaceuticals January 2016
Big Pharma continues to acquire biotechs to replenish its R&D pipeline, as transactions are done increasingly in the earlier R&D stages. KPMG’s Deal Thermometer indicates that the environment for M&A activity will remain ‘Hot’ in pharmaceuticals.
Integrated control systems: new opportunities and cyber risks for chemical manufacturers
Once designed to operate in isolation, chemical manufacturing control systems are now being connected to the virtual world.
Cash is always king: How chemical companies are optimizing their working capital management
During the global downturn, working capital management was top of mind for the chemical industry. With today’s increased revenues and ready access to cheap debt, companies might feel that they have fewer incentives to change their processes.
Companies in the energy and natural resources (ENR) sector face an increasingly complex operating environment around the world, not least in the field of compliance – and especially in the area of anti-bribery and corruption (ABC).
Deal Capsule: Transactions in Chemicals - Q3 - 2015
While the specialty chemicals segment remained attractive, consolidation in the agrochemical sector was another key deal driver, accounting for three of the top 10 announced deals during Q1-Q3 2015.
Deal Capsule: Transactions in Pharmaceuticals - Q3 - 2015
KPMG’s Deal Thermometer indicates that the environment for M&A activity will remain ‘Hot’ in pharmaceuticals.
Global automotive industry growth driving demand for chemical products
With few exceptions, the global automotive industry has made a solid recovery from the downturn in 2008.
Building the 21st Century: chemicals and the global construction industry
Specialty chemicals have helped shape today’s global construction industry, introducing new levels of structural strength.
Deal Capsule: Transactions in Chemicals & Pharmaceuticals
This report includes disclosed and undisclosed values for M&A transactions including minority stake purchases, acquisitions of remaining interest, and recapitalizations and it explicitly excludes self-tenders and spinoffs.
Unlocking the Value of Social Investment
This edition of Sustainable Insight explores corporate and foundation approaches to measuring and reporting social investment, and presents a framework to help companies improve the effectiveness of social programs.
A changing industry for India’s chemical companies
As one of the emerging “tiger economies” of Asia, India has long enjoyed rapid growth.
China's 12th Five-Year Plan: Chemicals
China's traditional export driven business model, with its emphasis on cost competitiveness, standardisation and middle-to-low technological content, is being eclipsed by new economic drivers and priorities in China.
China's chemical industry enters a new era with sustainability
Green economy as a game-changer and growth driver. China is trying to transform its powerful industrial model into an economy driven by sustainability.
© 2025 Copyright owned by one or more of the KPMG International entities. KPMG International entities provide no services to clients. All rights reserved.
KPMG refers to the global organization or to one or more of the member firms of KPMG International Limited (“KPMG International”), each of which is a separate legal entity. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. For more detail about our structure please visit https://kpmg.com/governance.
Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.